Structure

InChI Key MINDHVHHQZYEEK-HBBNESRFSA-N
Smiles C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O
InChI
InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H44O9
Molecular Weight 500.63
AlogP 2.59
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 16.0
Polar Surface Area 146.05
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 35.0

Bioactivity

Mechanism of Action Action Reference
Isoleucyl-tRNA synthetase inhibitor INHIBITOR DailyMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Ligase
- 1 - 60-15000 -
Assay Description Organism Bioactivity Reference
Compound was evaluated for inhibitory activity against Isoleucyl-tRNA synthetase Escherichia coli 0.8 nM
Inhibition concentration against Isoleucyl-tRNA synthetase from Staphylococcus aureus NCTC 6571 Staphylococcus aureus 0.00085 ug.mL-1
Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureus 11481 Staphylococcus aureus 0.14 ug.mL-1
Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureus C 7 Staphylococcus aureus 20.0 ug.mL-1
Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureus NCTC 6571 Staphylococcus aureus 0.0008 ug.mL-1
PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1900 (Counter Screen), 1677 (Project Summary), 1902 (Retest at Dose), 1662 (Primary HTS)] Streptococcus 60.0 nM
PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)] Streptococcus 60.0 nM
PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)] Streptococcus pyogenes M1 GAS 60.0 nM
PUBCHEM_BIOASSAY: Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1902 (Retest at Dose), 1900 (Counter Screen), 1662 (Primary HTS)] Streptococcus pyogenes M1 GAS 423.0 nM
Competitive inhibition of Escherichia coli Isoleucyl-tRNA synthetase Escherichia coli 2.5 nM
Inhibition of Spinacia oleracea (spinach) chloroplast isoleucyl tRNA synthetase at 1 uM Spinacia oleracea 75.0 %
Inhibition of recombinant Thermus thermophilus HB8 wild type IleRS assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation Thermus thermophilus HB8 250.0 nM
Inhibition of recombinant Thermus thermophilus HB8 IleRS L583F mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation Thermus thermophilus HB8 60.0 nM
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 26.23 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 13.89 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 14.73 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.07 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.25 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.07 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.25 %

Related Entries

Cross References

Resources Reference
ChEBI 7025
ChEMBL CHEMBL719
DrugBank DB00410
DrugCentral 1857
FDA SRS D0GX863OA5
Human Metabolome Database HMDB0014554
Guide to Pharmacology 10916
KEGG C11758
PDB MRC
PharmGKB PA164764568
PubChem 446596
SureChEMBL SCHEMBL3291
ZINC ZINC000004102194